CENTER FOR SUSTAINABILITY AND HUMAN RIGHTS

Governance Systems for AI, ESG and Human Rights Risk

Building cross-border governance frameworks for midmarket leadership and Private Equity investors to map data readiness, manage algorithmic bias, and support commercial revenue.

SCHEDULE A CONSULTATION

SERVICES

Three pillars, one connected system: AI Governance, ESG, and human rights due diligence.

For midmarket healthcare, manufacturing, and logistics businesses, unmanaged exposure to AI, ESG, and human rights can lead to lost revenue and lower valuations. We build governance systems to mitigate that risk.

Pillar 1—AI Governance

AI Governance in clinical, operations, and value chain settings.

We put a structure in place to deploy, evaluate, and govern AI. This includes who owns it, the documentation to back it, and how it's monitored over time. Critical in healthcare, medtech, and value chain environments, where AI and technology move faster than regulations evolve, raising questions about fairness, safety, and oversight.

Includes:

AI Inventory and use case mapping
Governance and accountability structures
Vendor and third-party AI governance
Reporting preparation for cross-border mandates: EU AI Act, CA SB 942 (watermarking), CA SB 1120 (physicians make decisions), and CA AB 3030 (AI in healthcare).

Best fit:

Healthcare systems, MedTech, and digital health companies, as well as medical supply and consumer goods value chains.

Outcome:

Leadership knows where AI risk resides, who owns it, and what evidence backs their oversight.

Pillar 2—ESG Governance

Practical ESG governance for organizations under growing scrutiny and reporting pressure.

We improve how ESG risk is identified, assigned, and built into daily operations and procurement to prepare data for reporting. Built for midmarket organizations that need lean governance systems, not enterprise-scale reporting architecture.

Includes:

ESG governance reviews and gap assessments
Data readiness and reporting reviews
Framework alignment with EU ESRS, GHG Protocol, IFRS S1 & S2
Cross-border reporting preparation for direct and indirect exposure to CA SB 253 & SB 261
Board, executive, and investor briefing support

Best fit:

Midmarket manufacturers, healthcare organizations, and private equity portfolios.

Outcome:

Clearer understanding of exposure, ownership, and a governance system that evolves with shifting expectations.

Pillar 3—Human Rights Due Diligence

Governance for labor and human rights exposure in high-risk operating environments.

We help teams integrate human rights due diligence into sourcing, governance, and reporting. This provides clear upstream and downstream visibility across the value chain, suppliers, and technology.

Includes:

Human rights due diligence reviews and gap assessments
Supply chain and vendor risk mapping (Tier 1 and beyond)
Framework alignment includes UN Guiding Principles and OECD Guidelines
Portfolio-level exposure reviews for PE and asset managers

Best fit:

Complex, multi-tier value chains—healthcare, apparel, consumer goods, manufacturing, logistics—and PE platforms overseeing high-risk assets.

Outcome:

A credible system to evaluate and track human rights risk across operations and value chains.

Where these Pillars Intersect

Most clients need support in more than one area. AI Governance, ESG, and human rights overlap in decision-making and value chains. We help midmarket organizations move out of silos and into a consolidated system that leadership can effectively govern.

Regulatory Scope

The regulatory landscape spans more than a single list can capture. We apply cross-border frameworks tailored to each client's sector and reporting requirements. Commonly used frameworks: the ISO/IEC 42001, NIST AI RMF, EU ESRS, UK SRS, GHG Protocol, UNGPs, and OECD Guidelines.

We focus mainly on mandates arising from California, the U.S., UK, and EU, as they apply to AI governance, ESG/climate, and human rights due diligence in healthcare systems, MedTech, medical supply and apparel/beauty value chains, manufacturing, and logistics networks. Mandates can include: the EU AI Act, CA SB 942, CA AB 3030 & SB 1120, the EU CSRD, CA SB 253 & SB 261, the CSDDD, and the UK Modern Slavery Act.

When client data involves sensitive health or consumer metrics, our approach is informed by relevant data privacy standards, including HIPAA and GDPR.

SCHEDULE A DISCOVERY CALL

Preserve Your Market Access

Unmanaged exposure to AI, ESG, and human rights can erode revenue and valuation. Partner with CSHR and build governance that preserves both as regulations evolve.